Necrotizing fasciitis caused by cutaneous mucormycosis: case report

被引:0
作者
Eduardo Telich-Tarriba, Jose [1 ]
Christopher Perez-Ortiz, Andric [1 ]
Telich-Vidal, Jose [2 ]
机构
[1] Escuela Med Univ Panamer, Mexico City, DF, Mexico
[2] La Salle Univ, Hosp Angeles del Pedregal, Ctr Especialidades Quirurg, Mexico City 10700, DF, Mexico
来源
CIRUGIA Y CIRUJANOS | 2012年 / 80卷 / 05期
关键词
zygomycosis; cutaneous mucormycosis; necrotizing fasciitis; mucorales; HYPERBARIC-OXYGEN THERAPY; CLINICAL-MANIFESTATIONS; ZYGOMYCOSIS; INTERFERON; MANAGEMENT; ADULT; GAMMA; INDIA;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Mucormycoses are opportunistic infections with high morbidity and mortality caused by fungi of the class Zygomycetes. They mainly affect diabetic and immunocompromised patients. In up to 20% of all cases, the primary infection is localized in the skin with a great number of cases presenting in healthy patients who have suffered severe trauma or burns. Zygomycetes tend to invade an artery, which leads to thrombosis and generates wide necrotic areas, favoring the progress of the infection and invasion of deep tissues. Up to 24% of cases of primary cutaneous mucormycosis can be complicated with necrotizing fasciitis. Clinical Case: We present the case of a 52-year-old male with a clinical diagnosis of necrotizing fasciitis. The patient received broad-spectrum antibiotics and was submitted to extensive debridement of the wound bed. Intraoperative biopsy revealed the presence of zygomycetes in the tissues, and diagnosis of primary cutaneous zygomycosis was made. Antifungal treatment with amphotericin B was initiated and 2 weeks later autologous skin grafts were applied over the wounds. Conclusion: A high index of suspicion is needed to diagnose cutaneous zygomycosis; therefore, it should always be considered among the differential diagnoses of necrotic wounds unresponsive to standard treatment. Rapid evolution of the disease reinforces the importance of early biopsy of the wound bed and aggressive treatment.
引用
收藏
页码:432 / 435
页数:4
相关论文
共 24 条
[1]   Interferon-γ and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children [J].
Abzug, MJ ;
Walsh, TJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (08) :769-773
[2]   Cutaneous mucormycosis: report of five cases and review of the literature [J].
Arnaiz-Garcia, M. E. ;
Alonso-Pena, D. ;
del Carmen Gonzalez-Vela, M. ;
Garcia-Palomo, J. D. ;
Sanz-Gimenez-Rico, J. R. ;
Arnaiz-Garcia, A. M. .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2009, 62 (11) :E434-E441
[3]   Hyperbaric oxygen therapy for cutaneous/soft-tissue zygomycosis complicating diabetes mellitus [J].
Bentur, Y ;
Shupak, A ;
Ramon, Y ;
Abramovich, A ;
Wolfin, G ;
Stein, H ;
Krivoi, N .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 102 (03) :822-824
[4]   Mucormycosis presenting as a renal mass in a patient with the human immunodeficiency virus [J].
Carvalhal, GF ;
Machado, MG ;
Pompeo, A ;
Saldanha, L ;
Sabbaga, E ;
Arap, S .
JOURNAL OF UROLOGY, 1997, 158 (06) :2230-2231
[5]  
Chander J, 2010, INDIAN J MED RES, V131, P765
[6]  
Chen C. K., 2008, Hong Kong Medical Journal, V14, P314
[7]   Zygomycosis [J].
Elgart, ML .
DERMATOLOGIC CLINICS, 1996, 14 (01) :141-+
[8]   Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases [J].
Jain, Deepali ;
Kumar, Yashwant ;
Vasishta, Rakesh K. ;
Rajesh, Logasundaram ;
Pattari, Sanjib K. ;
Chakrabarti, Arunaloke .
MODERN PATHOLOGY, 2006, 19 (09) :1221-1226
[9]   Invasive zygomycosis: Update on pathogenesis, clinical manifestations, and management [J].
Kontoyiannis, Dimitrios P. ;
Lewis, Russell E. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2006, 20 (03) :581-+
[10]   Efficacy of Liposomal Amphotericin B Combined with Gamma Interferon or Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Systemic Zygomycosis in Mice [J].
Mar Rodriguez, M. ;
Calvo, Enrique ;
Marine, Marcal ;
Javier Pastor, F. ;
Fernandez-Ballart, Joan ;
Guarro, Josep .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) :3569-3571